Rapid Novor

Rapid Novor helps biotech and pharmaceutical companies extract the full potential of antibodies in ways never before possible. We provide services and develop new technology that enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics. Our technology has the potential to unlock a new universe of discoveries that will shape future research, and benefit global health. At Rapid Novor, we believe that the journey to a world of more effective treatments that cost less and are easier to develop starts with decoding immunity.